Abstract
Introduction
Autoimmune thyroid disease (AITD) is viewed as a multifactorial condition in which the development of the autoimmune response against thyroidal antigens is facilitated by a particular but still incompletely known polygenetic background and presumably provoked by environmental factors. Identified environmental factors are iodine intake, smoking, stress, pregnancy, estrogens and possibly infections. Infections have been implicated in the pathogenesis of a number of autoimmune diseases like Coxsackievirus P2-C in type 1 diabetes mellitus [1] , but their role in AITD is disputed. The best studied infection in AITD is that with Yersinia enterocolitica (YE). The membrane of YE has specific TSH binding sites [2] , and infection with YE gives rise to antibodies against these TSH binding sites which recognize and stimulate the TSH receptor of human thyroid membranes [3, 4] . Conversely, Graves IgG bind to YE membranes [5] . Thus, YE infection by molecular mimicry with self antigens may induce crossreactive TSH receptor antibodies and crossreactive T-cells, leading to AITD. YE furthermore acts as a superantigen [6] , and may result via induction of V-gene restricted T-cells in polyclonal stimulation of autoreactive T-cells, again contributing to the development of AITD.
Whereas the laboratory data provide a solid base for assuming an etiologic role of YE infection in AITD, clinical evidence in support of this hypothesis has been inconclusive as conflicting results are reported on the frequency of YE infection in AITD patients compared to controls as summarized in Table 1 [7] [8] [9] [10] [11] [12] .
How are these discrepant results explained? Geographical differences in exposure to YE might be one reason. Differences in the applied methods to measure YE seroreactivity could be another. Serologic evidence of YE infection can be obtained by the agglutination reaction, which however becomes rapidly negative. All pathogenic Yersinia species harbour a 70 kb plasmid encoding for the virulence conferring outer membrane proteins (YOPs) [7, 8] . A more suitable method therefore is the demonstration of specific IgA and IgG antibodies against YOPs by ELISA or immunoblots. Methodological differences, however, are unlikely accountable for the sharp contrast between positive and negative studies when similar methods are used. A third possibility is that the studies were done too late in the course of the disease. Indeed, all reported studies in the literature are cross-sectional in nature, investigating serum samples of patients who already had developed full blown Graves' hyperthyroidism or Hashimoto's hypothyroidism and who mostly had been treated for months to years. Although it has been reported that IgA and IgG antibodies in newly diagnosed patients with Graves' hyperthyroidism are not observed until four weeks after diagnosis [15] , patients rarely remember any symptoms of a recent Yersinia infection [10] . We hypothesized that looking earlier in the natural course of the disease (i.e. when thyroid function is still normal but thyroid antibodies are already present) might increase chances to find evidence for YE infection. For, IgA antibodies appear after 10 days postinfection, followed by IgG antibodies.
IgA reactivity decreases rapidly after 3-6 months, whereas a decrease of IgG is markedly retarded. In chronic infection persistent IgA and IgG reactivity is seen [7] .
To pursue this further, the question is how to find subjects with subclinical AITD. Female relatives of patients with Graves' hyperthyroidism or Hashimoto's hypothyroidism are clearly at risk to develop AITD in view of their gender and family history [16, 17] . We have assembled a large group of such subjects in the Amsterdam AITD cohort study, designed as a long-term prospective follow-up study to get more insight in genetic and environmental factors involved in the pathogenesis of AITD [18] . Here we report the results at study entrance for YE seroreactivity, which was assayed blindly with respect to the thyroid state. As comparison we recruited healthy euthyroid volunteers. Serum samples of both groups were collected over the same period of time.
Subjects and Methods
The Amsterdam AITD cohort comprises 803 female subjects between 18 and 65 years of age with at least one 1st or 2nd degree relative with documented autoimmune hyper-or hypothyroidism; they had no personal history of thyroid disease and were in self-proclaimed good health. All subjects were seen at our institution, and blood was drawn after obtaining informed consent; plasma and serum samples were stored at -20° C until assay. The significance of differences between groups was analyzed with the X 2 test, or with Fisher exact test in case of small numbers. P-values are two tailed.
Results
The prevalence of TPO antibodies and of IgG and IgA antibodies against YOPs were higher in AITD relatives than in controls ( Table 2 ). The AITD relatives were on average nine years younger than control women, but the higher prevalence of YOP antibodies in AITD relatives was similar in all age groups (Table 3) . The majority (94.5%) of AITD relatives were euthyroid as evident from a normal TSH, but 3.6% were hypothyroid (plasma TSH >5.7 mU/l) and 1.9% were hyperthyroid (plasma TSH hypothyroid and hyperthyroid AITD relatives ( Table 2 ). 
Discussion
The main finding of the present paper is a higher prevalence of IgG and IgA antibodies to released virulence-associated outer membrane proteins (YOPs) of Yersinia enterocolitica in female relatives of patients with autoimmune thyroid disease than in control women. The validity of this finding depends heavily on the characteristics of the control group: are these comparable to the AITD relatives? All investigated subjects were in self-proclaimed good health and of female sex, but the control women were on average eight years older. However, the difference in age is unlikely to account for the difference of 16.1% (95% CI 16.0-16.2) in the prevalence of YOP IgG-Ab between both groups, nor for the difference of 9% (95% CI 8.9-9.1) in the prevalence of YOP IgA-Ab, because the presence of YOP antibodies was similar in all age groups. Blood samples of both groups were collected over the same time period, excluding bias due to seasonal variation in Yersinia infection. Control women orginated from Amsterdam and surrounding areas, but AITD relatives came from all over The Netherlands. Confounding bias due to some variation in places of residence seems unlikely as no specific geographic distribution of Yersinia infections has been reported in The Netherlands. Measurement bias can be ruled out because all assays of YOP antibodies were done 'blindly' using one particular method. The groups differed in thyroid function: control women were all euthyroid, but 5.5% of the female AITD relatives were either hypo-or hyperthyroid. However, thyroid function by itself does not explain the difference in YOP antibodies between both groups: the prevalence of YOP antibodies was equally high in hypo-, hyper-and euthyroid AITD relatives, and the difference in prevalence of YOP antibodies between euthyroid AITD relatives and controls was the same as between the whole group of AITD relatives and controls.
Can the higher prevalence of YOP antibodies in AITD relatives be explained from the difference in prevelance of AITD between both groups? The presence of serum TPO antibodies is a good marker for the existence of chronic autoimmune thyroiditis [19] .
According to this criterion AITD was present in 10% of control women, a figure in good agreement with the prevalence of AITD in the adult female population [20] . As expected, we found a much higher prevalence of AITD of 27% in the female AITD relatives. Nevertheless, the difference in prevalence of AITD between both groups cannot be held accountable for the difference in prevalence of YOP antibodies as the presence of YOP antibodies in euthyroid relatives was not related at all to the presence of TPO antibodies. One may argue that our cutoff value of >100 kU/l in the TPO-Ab assay as criterion for a positive TPO-Ab test, is too high. For, the detection limit of the assay is 50 kU/l, and values between 50 and 100 kU/l The lack of association between seroreactivity against YE and AITD argues against Yersinia infection as a causal factor contributing to the development of AITD. We found no support for our initial hypothesis that chances to observe such an association would be enhanced by looking earlier in the natural course of AITD, i.e. when thyroid function is still normal but thyroid antibodies are already present. The limitations of the present study are, however, the same as of those reported so far in the literature: they are all cross-sectional in nature. It cannot be completely excluded that during prospective long-term follow-up, as foreseen in our Amsterdam AITD cohort study, the occurrence of TPO antibodies or an abnormal thyroid function bears a temporal relationship to a previous rise of YOP antibodies. Such an observation would strengthen a cause-and-effect relationship.
Having ascertained the validity of the comparison group and the lack of an association between YOP antibodies and AITD, how must the higher prevalence of YOP antibodies in AITD relatives be interpreted? Yersinia virulence plasmids encoding for YOPs have not been found in other enterobacteriacaea. The measured YOP antibodies are apparently specific for YE, and a fair proportion of our investigated subjects must have experienced YE infection.
Indeed, Yersiniosis seems a rather common disease in The Netherlands [7] . The lower prevalence of YOP IgA-Ab relative to IgG-Ab indicates that YE infection in our adult subjects must have occurred somewhere in the past and not in recent times. In line with this are demographic data of 261 Dutch patients with enteric forms of Yersiniosis [7] : 40.2% had occurred in the age group of 0-15 years, 18% between 16 and 25 years, and 41.8% in patients olders than 25 years.
Our data do not necessarily indicate a higher incidence of YE infection in AITD relatives. This is because, in 65% of patients with yersiniosis, the infection is self-limiting, but in 35% a chronic infection persists with high titres of YOP IgG-Ab and IgA-Ab due to continuous antigenic stimulation from the plaques of Peyer and other lymph nodes still harbouring YE [21] . Why YE infection may persist in some subjects but is self-limiting in others must be determined by host factors. Experimental animal models suggest that the immune state is an important determinant [22] . In human and in mice, a relationship has been noted between the infection pattern and the HLA-B27 antigen [23, 24] . Following this line of reasoning, it could be that the higher prevalence of YOP antibodies in AITD relatives is not caused by a higher incidence of YE infection per se, but by a higher rate of persistent YE infection caused by a particular genetic make-up. Some of the susceptibility genes for AITD (like those of the HLA family and CTLA-4) may also confer a risk for persistence of YE infection. For, unlike individuals constantly exposed to infections, individuals living under hygienic conditions (as in the Netherlands) are poor regulators of immune responses in general. According to the 'hygiene hypothesis' the decreased infections and antigenic pressure of a westernized lifestyle may result in an increased incidence of allergic and organ-specific autoimmune diseases [25, 26] . We consider this possibility as the most attractive explanation of our results.
